Investor Ideas #Potcasts
519, #Cannabis News and #Stocks on the Move; (CSE: $CRFT.C) (TSX.V: $WMD.V)
(TSX: $WLLW.TO) (CSE: $IPOT.C)
Delta, Kelowna, BC, January 19, 2021 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/011921-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/01191CRFT-WMD-WLLW-IPOT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public company announcements.
BC
Craft Supply Co. Ltd. (CSE: CRFT) (OTC:CRFTF) announced that it entered into a binding
letter of intent on January 15, 2021, to acquire 100% of the issued and
outstanding shares of Ava Pathways Inc., from arm’s length parties .
Based in Vancouver, BC, Ava Pathways
is an innovative company that is exploring the therapeutic scientific benefits
of proprietary formulations, using compounds from mushrooms. Ava Pathways was founded by scientists and
researchers focused on neuroplasticity and alternative ways to treat common and
debilitating medical conditions such as depression, anxiety, PTSD, and
substance use disorder, through the use of psychedelic-based treatments.
Similar to craft cannabis, both plant-based treatments require a cultivation
supply network to create proprietary strains that produce optimal results for
the patient or end-user. Ava Pathways
brings exceptional access to tested and standardized naturally-derived and
synthetic materials which allows for the production of superior psychoactive
and non-psychoactive formulations.
BC Craft has been a pioneer in the
craft cannabis sector since pre-legalization and continues that mission by
acting as a comprehensive solution partner to other plant-based craft companies
while advocating on their behalf. Ava
Pathways embodies that same compassionate mentality with the end-users
well-being in mind. Ava Pathways has
over twenty collective years of experience and relationships in strong
pre-clinical and clinical experimental programs that aim to provide patient and
data-driven treatment through a robust clinical treatment network, which
combine holistic and personalized treatment plans, therapy and education. Ava
Pathways is headed up by CEO Dr. Lily Aleksandrova, a published expert in the
field; Dr. Aleksandrova completed her Ph.D. in Neuroscience at UBC and boasts
10+ years of research experience in neuroscience, pharmacology and clinical
research labs investigating novel neuropsychiatric treatments.
Matthew Watters, CEO of BC Craft
stated, “We are delighted by the opportunity to bring Dr. Lily Aleksandrova and
Ava Pathways into the BC Craft family, and into the long-term strategic
direction of the Company which seeks to commercialize high-end artisanal brands
in the cannabis industry, and in the emerging psychedelic space when the legal
framework should allow." Mr. Watters goes on to state, “The LOI with Ava
Pathways comes at an opportune time whereby the use of psychedelic compounds
such as psilocybin in functional medicine has gained widespread and
scientifically backed support from researchers as well as an increased social
acceptance from the broader population.”
WeedMD
Inc.
(TSX-V:WMD) (OTCQX:WDDMF) announced that it is kicking off 2021 with the
development of new extract products featuring live resin and solventless hash,
and rosin concentrates. The Company’s newest Cannabis 2.0 extract products are
expected to debut during the second quarter of 2021, under WeedMD’s Color
Cannabis and Saturday Cannabis adult-use brands.
“WeedMD’s genetic library boasts
unique strains, with flavour and aroma profiles widely recognized throughout
the industry and we are thrilled to announce we are now expanding into
high-value, terpene-rich hash, live resin and rosin products,” said George
Scorsis, Executive Chairman and Interim CEO, WeedMD. “We are listening to our
consumers and retail partners in developing these products and extending our
portfolio. Our cultivation, commercial and product teams are now capturing
these profiles in a variety of formats including solventless concentrates and
extracts to deliver premium products under our Color and Saturday Cannabis
brands. This expanded portfolio is tailor-made for consumers looking for richer
cannabis concentrates and alternative cannabis consumption methods.”
Product development for both
solventless cannabis concentrates (including bubble hash and rosin) and
hydrocarbon (live resin) extract products is currently underway alongside
WeedMD and its highly skilled third-party processors. This includes trialing
processes to produce extracts which best capture and preserve the Company’s
most robust, trichome-coated flowers, including award-winning strains such as
Pedro’s Sweet Sativa and Mango Haze.
The Company has further developed a
unique, in-house sub-critical CO2 extract post-processing
methodology, which preserves the flower’s terpene profile and results in a
malleable, semi-solid high-potency cannabis extract product. Trials to confirm
scalability and product integrity are currently underway at the Company’s
Aylmer, Ontario processing and extraction hub.
Extract products will be produced
using WeedMD’s own biomass, grown on site at the Company’s state-of-the-art
greenhouse and outdoor field in Strathroy, Ontario. Initial new extract
products are anticipated for market release in Q2 2021.
Willow
Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) announced that it has advanced its work on its
proprietary yeast strain for production of Tetrahydrocannabinol
("THC"), and plans to commercially launch in the Canadian market.
"We are excited to announce our
proprietary THC yeast biosynthesis production process for launch in the
Canadian market," said Trevor Peters, Willow's President and Chief
Executive Officer. "Our platform technology enables us to produce a
variety of cannabinoids and leverage our previous work on CBG. From
conversations with prospective customers in Canada, we believe that there is
significant demand for consistent, high-purity THC. The flavourless, odorless
attributes of our finished product make it suitable as a core ingredient for
the cannabis 2.0 market in Canada. There is also strong demand for a more
sustainable and environmentally friendly way to produce THC. Our manufacturing
process is 50 to 500 times more efficient than indoor cultivation and is the
next evolution of sustainable cannabinoid manufacturing."
The Company's Canadian based
research and development group has developed a proprietary yeast strain and
process for the production of THC and is working toward a pilot scale run later
this year. While there is already a well-established market for THC in Canada,
the Company believes there is significant demand from consumer product manufacturers
looking for a consistent, high-purity, odorless, flavourless THC ingredient
like Willow's for the 2.0 market, which consists of vapes, edibles, beverages,
concentrates and topicals. The THC market for 2.0 products is already a
multi-billion-dollar, multi-ton addressable market for Willow to sell into. The
Company has identified a development partner for product isolation,
purification and scale up to pilot and is in talks with several manufacturing
companies in Canada to serve the adult-use market.
Willow will launch its THC into the
Canadian adult-use market first due to its highly-regulated, legal and
developed status. The Company is carefully watching the developments in the
United States surrounding potential legalization and will be ready to react to
any positive regulatory changes should they arise.
Isracann
Biosciences Inc. (CSE: IPOT) (OTC: ISCNF) an Israel-based company focused on
becoming a premier low cost, high quality cannabis producer, provided a year end summary of activities and
outlook for 2021.
There is a sense of relief that 2020
is now behind us. Over the course of the past year, the impact of COVID-19 has
been felt around the globe and will undoubtedly continue to impact countless
lives and entire economies for years to come. While many difficulties remain
before us all, a guarded optimism is growing daily. The challenges that
directly impacted our venture were principally logistical and operational in
nature and affected most of the sector equally. Given the Israeli governments
increasingly pragmatic outlook regarding cannabis we remain extremely
optimistic regarding our ability to achieve our strategic goals for the new
year.
In consideration of the disruptive
nature of the pandemic, Isracann is nonetheless extremely pleased to have made
continued progress at both its domestic operations. At our early-stage Nir,
Israel farm, the Company was required to realign elements of its submission to
the Settlement Commissioner for the Nir region, which was expedited via the
invaluable aid of our regional consultants. This process has paved the way for
a formal application to the Ministry of Health. In all other respects the
project is poised for fast-tracked completion with commencement of operations
to occur as soon as approval is received.
The agreement and commitment to
accelerate the completion of the flagship Hefer Valley-based Ein Hahoresh Farm
has proven to be a key driver for the Company. With 165,000 sq. ft. of greenhouse
canopy and extensive processing capability in-place, the Company and its
regional partners are moving rapidly towards industrial-scale operations
capable of servicing both the domestic and increasingly important European
export markets in 2021.
Per recently amended regulations
that require all physical facilities to be completed and approved prior to
planting, the construction activities at the Ein Hahoresh farm expanded the
onsite post-harvest facility in preparation for commencement of operations and
increased demand from growing domestic and export markets. We are well poised
to, in the short term, complete the facility and receive the required Security
and Ministry of Health approvals to acquire our farm operating license and
start planting. Consequently, Isracann and its local consultants are currently
scheduling the commencement of planting in March to coincide with the start of
optimal climatic conditions. Additionally, applications for certification of
Isracann as foreign cannabis cultivation license owners were submitted to the
Ministries of Security and Health, which upon acceptance, will result in
Isracann’s ability to formally complete any remaining aspects of our joint
venture acquisition.
While completion of our farms is the
primary focus of the company, we have been actively initiating and expanding
our visibility and relationships across the region and onwards into Europe. Our
goal has been to establish infrastructural agreements aimed at launching
Isracann onto the world stage as a truly international cannabis enterprise. As
these pending activities are commercial in nature, and include multiple
parties, we look forward to announcing further details outlining our expanded
strategic outlook for the coming year as soon as possible.
Concurrently, the domestic
legislative, regulatory, and societal environment regarding cannabis
production, processing, distribution, and sales within Israel continues to
improve as do the opportunities for export operations. Last year saw several
landmark rulings and accelerated momentum that is rapidly transforming this
emerging sector into a respected national industry.
It is also worth mentioning that
Israel has been noted as an early leader in the distribution
of coronavirus vaccinations, and this appears to be driving optimism for the
entire business community throughout the region. Isracann and its team of
professional consultants are confident this will aid initial sales projections
upon entry into a domestic marketplace which is markedly more robust than ever
before.
Company CEO Darryl Jones comments,
“Since our decision to enter the market sector in Israel just 20 short months
ago, we have seen cannabis reform, including major advances in legalization,
production and distribution. We’ve also seen the door opening up for export
sales, and a wholesale shift in cultural acceptance. And yet we have had to
deal with some setbacks as the regional governments come to terms with new
regulations and the impact of a global pandemic. But one thing to remember is
that this is just the playing field, and it is the same field for everyone in
the sector. As players, we have engaged top industry professionals to consult
on our behalf, incorporated leading agronomic experts to show us the true path
to product excellence, and ensured our leadership includes a strong mix of
business and production expertise. We have a team with big league knowhow and
home field advantage, and this all translates into ability and confidence. We
are well positioned and well financed and are committed to ensuring that 2021
is the year Isracann gets fully into the game and starts to deliver the returns
we know its capable of. With that vision firmly in-place, we thank all our
supporters for your continued trust as we forge ahead to make this year an
outstanding opportunity for value creation through the intelligent application
of capital into predictably growth-focused areas of the global cannabis
industry.”
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Investors can
trade these stocks and other ideas on our site
using our list of top stock trading
apps including Robinhood , Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor
Ideas – news, articles, podcasts and stock
directory
